Emergency Medicine Update
Thursday, February 11, 2021
7:45 AM – 1:45 PM | Live via Zoom Webinar
ICEP’s winter CME conference is virtual and better than ever. Emergency Medicine Update is a multifaceted educational program for all emergency care providers — and you don’t have to leave your house to tune in live.
On the 2021 agenda:
COVID-19 in Children for Emergency Medicine • Pediatric Sedation in the ED • Best Practices for Traumatic Spinal Injury • Top 10 EM Articles of 2020 • Reversing Direct Oral Anticoagulants in the ED • ICEP Update
- Describe the incidence and characteristics of COVID-19 infection in children as well as identification and management of its complications, such as COVID-related rashes and MIS-C
- Discuss indications for pediatric sedation in the emergency department
- Review medication options, dosing, routes of administration, and their advantages and disadvantages
- Discuss how to choose an appropriate medication for the procedure to be performed
- Describe current issues and challenges facing the Illinois College of Emergency Physicians and the American College of Emergency Physicians
- Understand the clinical features of acute traumatic spinal cord injury and successfully apply current, evidence-based treatment in this patient population.
- Review current literature to outline important advances in emergency medicine from key articles in 2020
- Analyze the implications and limitations of the studies on the practice of clinical emergency medicine
Special CME Presentation:
Changing Course: Reversing Direct Oral Anticoagulants in the Emergency Department
How effectively are you managing DOAC-associated life-threatening bleeds in your emergency department?
Management of patients who require rapid reversal of urgent DOAC-associated bleeding is challenging. This CME activity will provide you with the tools you need to deliver individualized, safe, and effective care for these patients.
The development of direct oral anticoagulants (DOACs) has advanced the therapeutic landscape for the management of thromboembolic events. Specific agents that rapidly reverse the effects of DOACs are now available and offer safe and effective options for patients who experience an emergency DOAC-associated bleeding event.
Upon completion of this activity, learners should be better able to:
- IDENTIFY the signs and symptoms of severe bleeding in patients receiving DOAC therapy
- ASSESS anticoagulant activity in individuals who present with DOAC-associated bleeding or who require emergency surgery
- DETERMINE appropriate reversal agents based on the type of anticoagulant, dose, timing of last dose, and indication
- IMPLEMENT local protocols for evaluating patients and managing DOAC-associated bleeding
Jointly provided by American College of Emergency Physicians and Spire Learning
THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM PORTOLA PHARMACEUTICALS, INC.